Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkn's lymphoma patient.
作者信息
Unluturk Ugur, Aksoy Sercan, Yonem Ozlem, Bayraktar Yusuf, Tekuzman Gulten
出版信息
World J Gastroenterol. 2006 Mar 28;12(12):1978-9. doi: 10.3748/wjg.v12.i12.1978.
Abstract
摘要
相似文献
1
Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkn's lymphoma patient.
World J Gastroenterol. 2006 Mar 28;12(12):1978-9. doi: 10.3748/wjg.v12.i12.1978.
2
Cytomegalovirus enterocolitis in a patient with diffuse large B-cell lymphoma after chemotherapy with rituximab.利妥昔单抗化疗后弥漫性大B细胞淋巴瘤患者的巨细胞病毒性小肠结肠炎
World J Gastroenterol. 2006 Dec 7;12(45):7391. doi: 10.3748/wjg.v12.i45.7391.
3
Cytomegalovirus gastritis after treatment with rituximab.利妥昔单抗治疗后发生的巨细胞病毒性胃炎。
Endoscopy. 2009;41 Suppl 2:E199. doi: 10.1055/s-0029-1214855. Epub 2009 Jul 27.
4
Changes in hepatitis C virus antibody titer and viral RNA load in non-Hodgkin's lymphoma patients after rituximab chemotherapy.利妥昔单抗化疗后非霍奇金淋巴瘤患者丙型肝炎病毒抗体滴度和病毒RNA载量的变化
Int J Lab Hematol. 2009 Aug;31(4):468-70. doi: 10.1111/j.1751-553X.2008.01034.x. Epub 2008 Feb 14.
5
Rituximab in lymphoma with life threatening haemolysis.
Leuk Lymphoma. 2002 Aug;43(8):1711-2. doi: 10.1080/1042819021000003108.
6
[Generalized lymphadenopathy and B symptoms].
Internist (Berl). 2006 Sep;47(9):974; author reply 974.
7
Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab.一名正在服用利妥昔单抗的非霍奇金淋巴瘤患者感染戊型肝炎病毒后发生慢性肝炎。
Ann Intern Med. 2009 Mar 17;150(6):430-1. doi: 10.7326/0003-4819-150-6-200903170-00026.
8
Incidental findings on follow-up fluorodeoxyglucose positron emission tomography studies in lymphoma patients: beware the outlier.
Leuk Lymphoma. 2009 Jun;50(6):865-7. doi: 10.1080/10428190903030866.
9
Rituximab immunotherapy for non-Hodgkin's lymphoma.利妥昔单抗免疫疗法治疗非霍奇金淋巴瘤。
Cancer Biother Radiopharm. 1999 Aug;14(4):241-50. doi: 10.1089/cbr.1999.14.241.
10
Introduction.
Semin Oncol. 2004 Feb;31(1 Suppl 2):1.
引用本文的文献
1
Gastric Outlet Obstruction due to Cytomegalovirus Infection in an Immunocompromised Patient.免疫功能低下患者因巨细胞病毒感染导致胃出口梗阻
Case Rep Gastroenterol. 2009 Sep 12;3(3):280-285. doi: 10.1159/000228895.
2
Does rituximab increase the incidence of infectious complications? A narrative review.利妥昔单抗是否会增加感染并发症的发生率？一篇叙述性综述。
Int J Infect Dis. 2011 Jan;15(1):e2-16. doi: 10.1016/j.ijid.2010.03.025. Epub 2010 Nov 11.
3
Cytomegalovirus enterocolitis in a patient with diffuse large B-cell lymphoma after chemotherapy with rituximab.利妥昔单抗化疗后弥漫性大B细胞淋巴瘤患者的巨细胞病毒性小肠结肠炎
World J Gastroenterol. 2006 Dec 7;12(45):7391. doi: 10.3748/wjg.v12.i45.7391.
本文引用的文献
1
Recommended guidelines for the treatment of cancer treatment-induced diarrhea.癌症治疗引起的腹泻的推荐治疗指南。
J Clin Oncol. 2004 Jul 15;22(14):2918-26. doi: 10.1200/JCO.2004.04.132.
2
Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab.大剂量化疗联合自体血干细胞挽救及移植前利妥昔单抗治疗后出现的罕见病毒感染（进行性多灶性白质脑病和巨细胞病毒病）
Blood. 2002 Feb 15;99(4):1486-8. doi: 10.1182/blood.v99.4.1486.
3
Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder.使用利妥昔单抗治疗移植后淋巴增殖性疾病后巨细胞病毒感染的致命再激活。
N Engl J Med. 2001 Sep 27;345(13):1000. doi: 10.1056/NEJM200109273451315.
4
Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy.用嵌合抗CD20单克隆抗体与CHOP化疗联合治疗低度B细胞淋巴瘤患者。
J Clin Oncol. 1999 Jan;17(1):268-76. doi: 10.1200/JCO.1999.17.1.268.
Zotero 插件